KPV
Symbol Kp · MW 342 Da
Tripeptide derived from α-MSH studied for inflammation and gut healing.
- Discovered
- 1989
- Half-life
- 2-4 hours
- Approval
- Not FDA-approved
Quick facts
- Category
- Recovery
- Route
- Injectable
- Molecular weight
- 342 Da
- Half-life
- 2-4 hours
- Discovered
- 1989
- Approval status
- Not FDA-approved
Reported effects
- Anti-inflammatory
- Gut barrier support
- Skin healing
Overview
KPV is a short anti-inflammatory peptide made from three amino acids: lysine, proline, and valine. It is derived from alpha-MSH, a hormone involved in immune response and inflammation regulation. KPV is commonly researched for skin inflammation, gut health, immune balance, and irritation control. As a recovery peptide, it is often associated with calming overactive inflammatory responses rather than directly rebuilding tissue. KPV may be used in discussions about skin barrier support, inflammatory bowel research, wound healing, and immune system regulation. Its purpose is to help support a more balanced inflammatory environment in the body.
Evidence context
KPV evidence summary
Human clinical evidence
KPV has an approval context listed in the Peptidic database. Approved use still depends on the specific indication, formulation, labeling, and clinician guidance.
Animal, preclinical, or formulation evidence
KPV may be discussed in animal, preclinical, in vitro, or early-stage research contexts. Those evidence types are useful for orientation but should not be treated as equivalent to approved human indications.
Status and evidence strength
Peptidic lists the approval status for KPV as Not FDA-approved. The reported effects below are reference fields from the peptide database, not medical promises. Source links are included later on the page when available so readers can continue review from primary or reputable sources.
How it's taken
- Typical Administration
- Topical / Injectable
- Typical Dosage
- No established approved dosage; commonly referenced injectable range is 200–500 mcg daily; topical formulations commonly use low-percentage cosmetic concentrations
- Typical Frequency
- Injectable once or twice daily; topical once or twice daily
Dosing depends on the approved indication, formulation, titration schedule, and clinician guidance. This page is educational and not a substitute for medical advice.
Research sources
Source links included from peer-reviewed literature, clinical records, and medical databases for educational research context on KPV.
Internal links
Related peptides
Frequently asked questions
What category is KPV in?
KPV is listed in the Recovery category on Peptidic.
What route is KPV associated with?
KPV is associated with the injectable route in the Peptidic database. This is descriptive route context, not a use instruction.
Is KPV approved?
Peptidic lists the approval status for KPV as: Not FDA-approved. Approval details can vary by indication and jurisdiction.
Interested in KPV?
Enter your email and we'll send our recommended peptide vendor for educational research reference.
Review the peptide vendor research checklistEducational reference only · No spam · Unsubscribe anytime
For educational purposes only. Many peptides shown are research compounds and not approved for human use in all jurisdictions. Explore the full peptide database, peptide calculator, or peptide tracker.
Last reviewed for educational accuracy: 2026-06-01